Hyaluronic acid-functionalized halloysite nanotubes for targeted drug delivery to CD44-overexpressing cancer cells
Authors:
- Xiaoyun MoXMXiaoyun Mo
- Fuling WuFWFuling Wu
- Ying LiYLYing Li
- Xiulan CaiXCXiulan Cai
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Materials Today Communications
- Vol. 28
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis ResistanceJournal of Biological Chemistry, 2011
- Surface studies of halloysite nanotubes by XPS and ToF‐SIMSSurface and Interface Analysis, 2011
- Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to ApplicationsNano Letters, 2010
- Cytocompatibility and Uptake of Halloysite Clay NanotubesBiomacromolecules, 2010
- Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancerTrends in Pharmacological Sciences, 2009
- Structure and Performance of Polyamide 6/Halloysite Nanotubes NanocompositesPolymer Journal, 2009
- Dendrimer-Encapsulated Camptothecins: Increased Solubility, Cellular Uptake, and Cellular Retention Affords Enhanced Anticancer Activity In vitroCancer Research, 2006
- Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma PerspectiveCancer Research, 2006
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Mechanisms of Cancer Drug ResistanceAnnual Review of Medicine, 2002